AdvanSource Biomaterials Corp. (ASB) took a step backwards during the second quarter, when sales slid nearly 50 percent, but still managed to eke out a net profit for the three months ended Sept. 30.
The Wilmington, Mass.-based firm, which makes polymers used for medical devices, posted sales of $518,000 during the second quarter of fiscal 2010, down 47.6 percent compared with $989,000 during the same period last year.
Despite the revenue decline, AdvanSource reported net income of $191,000 for the quarter, compared with a net loss of $327,000 during Q2 2009. The company credited cost-cutting measures and a $729,000 contribution from the sale of its Gish Biomedical to Medos Medizintechnik AG.
AdvanSource slashed expenses during the quarter, cutting cost of sales by 23 percent and operating expenses by 19 percent, to $291,000 and $769,000, respectively.
Food & Drug Administration chief Margaret Hamburg calls the agency's $775 million budget-...
A clinical trial conducted by Medtronic of its Activa deep-brain stimulation device and epilepsy...
Salem, N.H.-based Guidewire Technologies earns a warning letter from the Food & Drug...
A Texas jury ruled that Smith & Nephew's Renasys-F negative-pressure wound therapy infringes...
The Food & Drug Administration grants PMA clearance to Abbott for its TECNIS intraocular lens,...